The likelihood of a serious side effect to occur from a second dose of a vaccine is “extremely rare”, if no side effects occurred after the first dose of the vaccine was administered, Acting Director of Pharmaceutical Services at the Cyprus Ministry of Health Elena Panayiotopoulou told CNA on Tuesday.
In statements to CNA, Panayiotopoulou stressed that the only instance the second dose is inadvisable is if someone has suffered with thrombosis and thrombocytopenia after receiving the first dose.
She further noted that people who have received the first dose and had some history of thrombosis before hand should still go ahead with the second dose, because if they do not complete their vaccination it will impact the vaccine`s efficacy.
Source: Cyprus News Agency